On 17 July 2026, James Hardie Industries PLC (ASX:JHX) issued 120,434 unquoted ordinary shares at USD 0.67480000 each as part of settling equity awards from its July 2025 merger with The AZEK Company Inc. This issuance marks the completion of post-merger equity obligations. The company secured an ASX waiver from Listing Rule 2.4 to enable this unquoted share issuance.
Key Points
- James Hardie Industries PLC (JHX) issued 120,434 unquoted ordinary shares on 17 July 2026
- Shares issued at USD 0.67480000 per share for cash consideration
- Issuance settles outstanding AZEK equity awards as of merger closing on 1 July 2025
- ASX granted waiver from Listing Rule 2.4 on 16 July 2025 to permit unquoted issuance
- Post-issuance, James Hardie holds 262,280,339 unquoted ordinary shares plus 318,238,223 quoted Chess Depositary Interests
Completion of Post-Merger Equity Award Settlement
James Hardie Industries PLC finalized the issuance of 120,434 unquoted ordinary shares on 17 July 2026, fulfilling equity award obligations from its merger with The AZEK Company Inc., which closed on 1 July 2025. This issuance settles AZEK equity awards outstanding at merger close, previously disclosed in a securities issuance announcement dated 24 March 2025.
The shares are unquoted and not listed on the ASX. James Hardie obtained a regulatory waiver from the ASX on 16 July 2025, exempting the company from Listing Rule 2.4 requirements for quotation, thereby facilitating a streamlined post-merger equity settlement process.
Issue Price and Cash Consideration Details
The 120,434 shares were issued for cash at USD 0.67480000 per share. The US dollar denomination aligns with James Hardie's operational context and the cross-border nature of the AZEK merger. The total cash consideration was not disclosed. The issue price reflects the valuation methodology agreed upon for settling AZEK equity awards post-merger.
This pricing approach ensures consistency and transparency in converting AZEK awards into James Hardie shares as per the merger agreement and equity settlement terms.
Company Overview and Market Position
James Hardie Industries PLC is a leading manufacturer and supplier of fiber cement building materials with significant operations in North America and Australia. Listed on the ASX, the company operates a dual-listed structure, offering products for residential and commercial construction markets across both regions.
The July 2025 merger with AZEK Company Inc. expanded James Hardie's product portfolio and geographic reach, enhancing its competitive position and operational synergies in the building products sector.
Regulatory Approval and ASX Waiver
To facilitate the unquoted share issuance, James Hardie applied for and received an ASX waiver from Listing Rule 2.4 on 16 July 2025. This waiver allowed the company to issue the shares without requiring ASX quotation, simplifying the post-merger equity award settlement and reducing administrative requirements.
Listing Rule 2.4 typically mandates quotation of certain securities on the ASX; the waiver reflects regulatory accommodation for cross-border merger equity settlements.
Capital Structure Post-Issuance
Following the issuance, James Hardie's capital structure includes 318,238,223 quoted Chess Depositary Interests (CDIs) traded on the ASX under ticker JHX, providing Australian investors access to the company’s shares.
Additionally, the company holds 262,280,339 unquoted ordinary shares, inclusive of the recent 120,434 shares. Other unquoted securities include 5,722,213 restricted stock units, 87,786 options expiring 15 June 2036 at USD 25.17 exercise price, and 269,221 options expiring 3 November 2027 at AUD 33.05 exercise price. This complex capital structure reflects post-merger integration and various equity instruments for talent retention and acquisition consideration.
AZEK Merger Timeline
The merger agreement was executed on 23 March 2025 and publicly announced on 24 March 2025, including notice of planned post-merger share issuances to settle equity awards. The merger closed on 1 July 2025, officially combining AZEK into James Hardie. The current share issuance was notified on 21 July 2026, nearly a year after closing.
The extended settlement timeline underscores the complexity of integrating and valuing diverse AZEK equity awards over the 12 months following merger completion.
Merger Consideration and Equity Award Settlement
The merger terms required converting AZEK equity awards into James Hardie securities as part of the consideration. These awards included restricted stock units and other long-term incentives vested or payable at or after merger close.
The 120,434 shares issued at USD 0.67480000 per share represent a tranche of this settlement. The company has not disclosed if further equity award settlements remain outstanding.
Unquoted Securities and Investor Implications
The issued shares are unquoted, lacking ASX trading liquidity and price discovery. Such shares are typically held by employees or award recipients and are restricted from public trading. Investors holding James Hardie CDIs should note the significant pool of unquoted shares totaling 262,280,339, which may pose potential dilution if converted or restructured in the future.
However, the restricted and unquoted status limits immediate dilution risk. Investors should monitor company disclosures for any changes affecting unquoted securities.
Future Outlook on Equity Settlements and Market Monitoring
This July 2026 issuance likely represents the final tranche of AZEK equity award settlements, though no confirmation was provided regarding remaining obligations. Investors should watch for future updates on any additional share issuances, RSU settlements, or option exercises.
Key upcoming milestones include updates on AZEK integration progress, synergy realization, and any capital structure or strategic changes disclosed in James Hardie's quarterly and annual reports.